User:Mr. Ibrahem/Fibrocystic breast changes

From Wikipedia, the free encyclopedia
Fibrocystic breast changes
Other namesFibrocystic change, fibrocystic breast disease,[1] fibrocystic breast condition
Micrograph showing fibrocystic breast changes. H&E stain.
SpecialtyGynaecology
SymptomsBreast pain, breast cysts, breast masses[2]
Usual onset30 to 50 years old[1]
Risk factorsEarly age at first menstrual period, having children late or not having children[2]
Diagnostic methodPeriodic examination, possibly medical imaging or breast biopsy[1]
Differential diagnosisBreast cancer[1]
TreatmentEducation about the condition, a well fitting bra, pain medication[1]
PrognosisGood[1]
FrequencyUp to 60% of women[3]

Fibrocystic breast changes is a condition of the breasts where there may be pain, breast cysts, and breast masses.[1] The breasts may be described as "lumpy" or "doughy".[3] Symptoms may worsen during certain parts of the menstrual cycle.[1] It is not associated with cancer.[2]

Risk factors include an early age at first menstrual period and either having children late or not having children.[2] It is not a disease but represents normal breast changes.[3] Diagnosis typically involves ruling out breast cancer.[1] Fibrocystic change includes fibroadenomas, fibrosis, and papillomas of the breast.[1]

Management may involve education about the condition, a well fitting bra, and pain medication.[1] Occasionally danazol or tamoxifen may be used for pain.[1] It is estimated that up to 60% of women are affected.[3] Women between the ages of 30 and 50 are most commonly affected.[1]

References[edit]

  1. ^ a b c d e f g h i j k l m Ferri, Fred F. (2018). Ferri's Clinical Advisor 2019: 5 Books in 1. Elsevier Health Sciences. p. 548. ISBN 9780323550765. Archived from the original on 2018-11-04. Retrieved 2018-11-03.
  2. ^ a b c d "Breast Masses (Breast Lumps)". Merck Manuals Professional Edition. Archived from the original on 29 October 2018. Retrieved 3 November 2018.
  3. ^ a b c d Santen, RJ; Mansel, R (21 July 2005). "Benign breast disorders". The New England Journal of Medicine. 353 (3): 275–85. doi:10.1056/NEJMra035692. PMID 16034013.